Berkshire Turns To Profit In Q1
Stock Alert: Mednax Jumps 15%
Shares of Mednax Inc. (MD) are gaining nearly 15% on Friday morning after the company reported its first-quarter results.
MD is currently trading at $30.71, up $3.95 or 14.76%, on the Nasdaq.
Mednax reported first-quarter profit of $17.6 million or $0.21 per share, compared to a loss of $18.7 million or $0.22 per share last year. Adjusted EPS from continuing operations were $0.24 per share. Mednax’s revenues gained to $446.8 million from $441.2 million a year ago.
Analysts polled by Thomson Reuters estimated earnings of $0.13 per share on revenues of $424.13 million.
Laura Ingraham Makes Stunning Claim About Gender-Neutral Pronouns
Surprise, surprise: Laura Ingraham can’t stand the gender-neutral pronouns they-them. (Watch the video below.)
The Fox News host on Thursday dedicated a segment to trashing the “systemic radicalism” of education, which includes teaching children more about the corrosive history of racism. (Learning!)
She eventually got around to gender identity, too, blasting the education site BrainPOP for teaching kids about “they” and “them,” pronouns embraced by many nonbinary people. Because who wants to teach kids to respect how others refer to themselves, right?
In an interview with the Hoover Institution’s Victor Davis Hanson and conservative author Dinesh D’Souza, Ingraham showed a snippet of BrainPOP’s grammar lesson on personal pronouns. She called it “very insidious.”
“It kind of takes the kids away from their family setting, or maybe their religious values ― whether you’re Muslim or Christian or Jewish, what have you, and breaks that bond,” Ingraham said. “The goal is to break the bond with the nuclear family.”
Check out Ingraham’s remarks and D’Souza’s eyebrow-raising response here:
H/T Media Matters
US added fewer jobs for April than expected, leaving economists disappointed
New York (CNN Business)Wall Street mostly brushed off the surprisingly weak jobs report, which showed far fewer jobs were added last month than expected.
The Dow and the S&P 500 were both up a bit Friday morning, and the Nasdaq soared 0.8% as big tech stocks bounced after a recent stretch lagging the broader market.
The jobs report also showed that the unemployment rate ticked up and wages surged. The jump in worker paychecks may not seem like a bad thing, it tends to set off alarm bells about inflation. And many economists are worried inflation is due to come roaring back because of all the stimulus from Washington.
Still, investors seemed unfazed Friday morning.
One possible reason for the rally is that investors may be betting that the Federal Reserve will not pull back on its easy money policies that have propped up financial markets anytime soon — something traders started to worry about after Treasury Secretary and former Fed Chair Janet Yellen recently suggested that rates may soon need to head higher.
Kaley Cuoco’s Yes, Norman Banner Lands Rights To Katie Russell’s ‘A Season With Mom’
EXCLUSIVE: Kaley Cuoco’s Yes, Norman Productions has acquired the rights to Katie Russell Newland’s A Season With Mom.
The book tells Russell’s story as a cancer survivor and baseball enthusiast, who embarks on the adventure of a lifetime: visiting all thirty Major League Baseball parks in one season. Along the way, she shares memories and reflections of her baseball-loving mother, who died of cancer before her and Katie could check this item off their bucket list together.
Harper Collins published the book on May 6.
A Season With Mom joins a long list of projects that Yes, Norman is currently developing which includes the second season of critically acclaimed The Flight Attendant, for which Cuoco received nominations for Golden Globes, SAG, Critics Choice, etc., the animated series Harley Quinn and the upcoming limited series about Doris Day.
Read More About:
The WHO is granting emergency use of China's Sinopharm COVID-19 vaccine
- WHO approved a COVID-1 vaccine from China’s Sinopharm for emergency use on Friday.
- The vaccine was developed by Sinopharm, a Chinese state-owned drugmaker, alongside the Beijing Institute of Biological Products.
- This is the first time WHO has authorized any Chinese-made vaccine for emergency use.
- See more stories on Insider’s business page.
A World Health Organization panel has authorized the emergency use of a COVID-19 vaccine made by China’s Sinopharm.
The vaccine was developed by Sinopharm, a Chinese state-owned drugmaker, alongside the Beijing Institute of Biological Products.
“This expands the list of Covid-19 vaccines that Covax can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO director Tedros Adhanom Ghebreyesus said at a press briefing, according to The Washington Post.
This is the first time that any Chinese-made vaccine has been granted emergency authorization by WHO.
This is a developing story. Please check back for updates.
Berkshire Turns To Profit In Q1
Billionaire Warren Buffett’s Berkshire Hathaway Inc. (BRK.A, BRK.B) reported a profit for the first-quarter compared to a loss in the prior year, reflecting stock-market gains.
The earnings report came ahead of its annual shareholder meeting, which will take place on Saturday at 1:30 pm ET in Los Angeles with both Buffett and Vice Chairman Charlie Munger present. The event will be held virtually without attendees for a second time.
Berkshire reported that its first-quarter net earnings attributable to shareholders was $11.71 billion or $7,638 per Class A share compared to a loss of $49.75 billion or $30,653 per Class A share in the same quarter last year.
Investment and derivative contract gains was $5.70 billion compared to loss of $70.28 billion in the previous year.
Insurance underwriting produced after-tax earnings of $764 million in the first quarter of 2021 compared to $363 million last year.
Quarterly operating earnings grew to $7.02 billion from $5.87 billion in the prior year.
Total revenues for the first-quarter rose to $64.60 billion from $61.27 billion in the previous year.